ImmunoPrecise Antibodies
IPA
#9890
Rank
$20.59 M
Marketcap
$0.45
Share price
-3.00%
Change (1 day)
-62.18%
Change (1 year)

Revenue for ImmunoPrecise Antibodies (IPA)

Revenue in 2025 (TTM): $17.17 Million USD

According to ImmunoPrecise Antibodies's latest financial reports the company's current revenue (TTM ) is $17.17 Million USD. In 2024 the company made a revenue of $17.17 Million USD a decrease over the revenue in the year 2023 that were of $17.49 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunoPrecise Antibodies from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $17.17 M-0%
2024 $17.17 M-1.86%
2023 $17.49 M13.53%
2022 $15.41 M1.17%
2021 $15.23 M18.24%
2020 $12.88 M35.84%
2019 $9.48 M22.57%
2018 $7.73 M132.18%
2017 $3.33 M497.54%
2016 $0.55 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A
2000 $0 M-95.76%
1999 $0 M-84.66%
1998 $0.03 M77852.27%
1997 $0 M